Peptide CDMO Market

Table of Contents

1. Executive Summary
   1. Introduction
2. Market Introduction
   1. Market Definition
   2. Scope of the Study
   3. Market Structure
3. Research Methodology
   1. Primary Research
   2. Research Methodology
   3. Assumptions & Exclusions
   4. Secondary Data Sources
4. Market Factor Analysis
   1. Value Chain Analysis: Peptide CDMO Market
   2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
5. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
6. Recent Trends Analysis
7. Impact of COVID-19 on Peptide CDMO Market
   1. Pre and Post Covid -19 Market Scenario Analysis
   2. Market Recovery Timeline and Challenge
   3. Measures Taken by Top Players
8. Regulatory Landscape
9. Peptide CDMO Market, Segment by Type
   1. Introduction
      1. Market Size and Forecast, Segment by Type
   2. APIs and Intermediates
      1. Market Size and Forecast, By Region
   3. Finished Dosage Forms (FDF)
      1. Market Size and Forecast, By Region
10. Peptide CDMO Market, Segment by Application
    1. Introduction
       1. Market Size and Forecast, Segment by Application
    2. Pharmaceutical
       1. Market Size and Forecast, By Region
    3. Academic Research
       1. Market Size and Forecast, By Region
11. Regional Overview
    1. Introduction
       1. Market Size and Forecast
    2. North America
       1. Market Size and Forecast
          1. Segment by Type
             1. APIs and Intermediates
             2. Finished Dosage Forms (FDF)
          2. Segment by Application
             1. Pharmaceutical
             2. Academic Research
       2. U.S.
          1. Segment by Type
             1. APIs and Intermediates
             2. Finished Dosage Forms (FDF)
          2. Segment by Application
             1. Pharmaceutical
             2. Academic Research
       3. Canada
    3. Europe
       1. Market Size and Forecast
          1. Segment by Type
             1. APIs and Intermediates
             2. Finished Dosage Forms (FDF)
          2. Segment by Application
             1. Pharmaceutical
             2. Academic Research
       2. U.K.
          1. Segment by Type
             1. APIs and Intermediates
             2. Finished Dosage Forms (FDF)
          2. Segment by Application
             1. Pharmaceutical
             2. Academic Research
       3. Germany
       4. France
       5. Spain
       6. Italy
       7. Russia
       8. Nordic
       9. Benelux
       10. Rest of Europe
    4. APAC
       1. Market Size and Forecast
          1. Segment by Type
             1. APIs and Intermediates
             2. Finished Dosage Forms (FDF)
          2. Segment by Application
             1. Pharmaceutical
             2. Academic Research
       2. China
          1. Segment by Type
             1. APIs and Intermediates
             2. Finished Dosage Forms (FDF)
          2. Segment by Application
             1. Pharmaceutical
             2. Academic Research
       3. Korea
       4. Japan
       5. India
       6. Australia
       7. Singapore
       8. Taiwan
       9. South East Asia
       10. Rest of Asia-Pacific
    5. Middle East and Africa
       1. Market Size and Forecast
          1. Segment by Type
             1. APIs and Intermediates
             2. Finished Dosage Forms (FDF)
          2. Segment by Application
             1. Pharmaceutical
             2. Academic Research
       2. UAE
          1. Segment by Type
             1. APIs and Intermediates
             2. Finished Dosage Forms (FDF)
          2. Segment by Application
             1. Pharmaceutical
             2. Academic Research
       3. Turky
       4. Saudi Arabia
       5. South Africa
       6. Egypt
       7. Nigeria
       8. Rest of MEA
    6. LATAM
       1. Market Size and Forecast
          1. Segment by Type
             1. APIs and Intermediates
             2. Finished Dosage Forms (FDF)
          2. Segment by Application
             1. Pharmaceutical
             2. Academic Research
       2. Brazil
          1. Segment by Type
             1. APIs and Intermediates
             2. Finished Dosage Forms (FDF)
          2. Segment by Application
             1. Pharmaceutical
             2. Academic Research
       3. Mexico
       4. Argentina
       5. Chile
       6. Colombia
       7. Rest of LATAM
12. Competitive Landscape, 2023
    1. Introduction
    2. Peptide CDMO Market Share Analysis, 2023 (%)
       1. Market Share Analysis, 2023
       2. Competition Ranking, 2023
       3. Key Developments & Growth Strategies
          1. Merger & Acquisition
          2. Product Launch
          3. Expansion
       4. Consolidated SWOT Analysis of Key Players
13. Company Profile
    1. Bachem
       1. Business Overview
       2. Financial Data
       3. Key Product Categories
       4. Recent Developments
    2. PolyPeptide
    3. AmbioPharm
    4. USV Peptides
    5. Thermo Fisher
    6. Bio Basic
    7. JPT
    8. Genscript
    9. Xinbang Pharma
    10. ScinoPharm
    11. SN Biopharm
    12. CBL
    13. Piramal Pharma
    14. CordenPharma
    15. CPC Scientific